Topic

Articles

And, in equal measure, patients and doctors—as EU mulls new rules.

Proposed SoHO reform elicits wide support, but risks acknowledged.

Legislative-reform alliance makes for strange bedfellows.

Group’s ideas to change EU pricing rules draw captive audience.

Investments setting up sector for future success that could one day rival its US counterpart.

Steve Scalia is president of Tanner Pharm Group

Bob Mulroy is director and chief executive officer of Partner Therapeutics

John L. McManus is chief business officer of Partner Therapeutics

Recent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity.

Damien O’Brien is the vice president of life sciences for IDA Ireland, the Irish government’s foreign direct investment agency

Recent growth in pharma makes Ireland an ideal candidate for expansion opportunities.

The risky business of outmaneuvering Europe’s drug pricing authorities.

Managing director, in-house counsel practice, Major, Lindsey & Africa

Brexit and the pandemic continue to complicate flow of international talent.

Fresh round of discussions around health technology assessment.